课题基金 / 基金详情

Transfusion Medicine/Hemostasis Clinical Research Netwo*

Transfusion Medicine/Hemostasis Clinical Research Netwo*
输血医学/止血临床研究网络*
批准号:
6662641
负责人:
DARRELL J TRIULZI
金额:
$29.47万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2007-08-31

项目摘要

项目成果

DARRELL J TRIULZI的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供): 核心中心计划目标:匹兹堡输血医学/止血研究网络(PTN)旨在通过利用我们的三大优势,为输血医学和止血领域的重要多中心临床试验做出贡献:1)匹兹堡大学输血医学研究所的教师向匹兹堡大学医学中心卫生系统(UPMCHS)的所有主要医院提供输血医学和凝血服务(ITxM); 2)UPMCHS医院提供的特殊患者基础,包括匹兹堡癌症研究所(PCI),成人和儿科I级创伤中心,最大的器官移植计划,儿童医院,妇女医院和门诊设施,包括西PA和PCI的血友病中心;以及3)所有三个核心中心研究者在运行和/或参与输血医学和止血的多中心临床试验方面的丰富经验和经验。 具体目标:我们提出了两个方案来实现这些目标:1)Activase预防血友病患者中心静脉穿刺器械感染的前瞻性随机试验。(项目1);和2)多中心,随机,血浆置换治疗与标准治疗血小板减少相关多器官功能衰竭患儿的临床对照研究(项目二)核心中心将提供成功实施和执行这些试验所需的基础设施和监督,包括:管理各协议的预算,及时建立项目网络办公室,协调各协议运行的资源(如,研究护士,数据员),确保新协议的及时实施和操作(例如,通过与方案研究者每两周一次的研究会议,建立每个方案的当地DSMB,协助方案研究者进行数据分析、解释和出版,建立社区咨询小组以教育社区并讨论和传播研究结果,并与其他网络站点合作选择和修订研究方案。
英文摘要
DESCRIPTION (provided by applicant): Core Center Program Objectives: The Pittsburgh Transfusion Medicine/Hemostasis Research Network (PTN) seeks to contribute to important multicenter clinical trials in transfusion medicine and hemostasis by capitalizing on our three strengths: 1) The integrated delivery of transfusion medicine and coagulation services to all the major University of Pittsburgh Medical Center Health System (UPMCHS) hospitals by the University of Pittsburgh faculty at the Institute For Transfusion Medicine (ITxM);2) The extraordinary patient base afforded by the UPMCHS hospitals including a Pittsburgh Cancer Institute (PCI), adult and pediatric level I trauma centers, a largest organ transplant program, a children's hospital, a women's hospital and outpatient facilities including the Hemophilia Center of Western PA and PCI; and3) The extensive experience and extertice of all three core center investigators in running and/or participating in multicenter clinical trials in transfusion medicine and hemostasis. Specific Aims: We propose two protocols to accomplish these objectives:1) Prospective Randomized Trial of Activase in the Prevention of Central Venous Access Device Infection in Hemophilia" (Project 1); and2) Multi-center, Randomized, Controlled Clinical Trial of Plasma Exchange Therapy vs Standard of Care in Children with Thrombocytopenia Associated Multi-Organ Failure (Project 2)The Core Center will provide the infrastructure and oversight necessary for the successful implementation and execution of these trials including: management of the budget for each protocol, timely establishment of program network office, coordinate resources for the operation of each protocol (e.g., research nurse, data clerk), assure timely implementation and operation of new protocols (e.g., accrural, timely data reporting, patient follow up) through biweekly research meetings with protocol investigators, establish a local DSMB for each protocol, assist protocol investigators with data analysis, interpretation, and publication, establish a Community Advisory Group to educate the community and to discuss and disseminate study results, and work with other network sites to select and revise study protocols.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DETERM OPTIMAL PROPHYLACTIC PLATLET STRATEGY PREVNT BLEED'G THROMBOCYTOPERIC
Retrovirus Epidemiology Donor Study-II (REDS-II) Blood Center
Retrovirus Epidemiology Donor Study-II (REDS-II) Blood Center
Transfusion Medicine/Hemostasis Clinical Research Network